Marketing-authorisation holder
Commave Sub
1 medicine in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1 medicine
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AZSTARYS10.4mg base; 52.3mg base | 5.2mg base; 26.1mg base | 7.8mg base; 39.2mg base · Capsule | Dexmethylphenidate, Serdexmethylphenidate | United States | Marketed | 2021 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 1 | 1 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 1
- Countries
- 1
- Roles
- Authorisation holder
Work with Prognia
Keep Commave Sub’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a call